KEYNOTE PRESENTATION: Infectious Disease Prevention and Care: Population Health Meets Personalized Medicine
Jay G. Wohlgemuth, MD, Senior Vice President and Chief Medical Officer, Quest Diagnostics and Chair, Personalized Medicine Coalition
The COVID-19 pandemic has resulted in many changes in how we think about and how we deliver healthcare. In particular, all arms of the healthcare ecosystem have had to understand and implement infectious disease prevention and care strategies to fight the pandemic. Through this collective experience, the field of infectious disease is now more clearly understood to be very much about personalized medicine with the mantra of, “right care, right person, right time” being critically important. In addition, it’s very clear that population health strategies are needed to bring personalized medicine rapidly, at scale, to the entire population in an effective way.
PANEL DISCUSSION: Diagnostic Testing to Mitigate Risk in COVID-19
Panel Moderator: Edward Abrahams, PhD, President, Personalized Medicine Coalition
- Examining the widely variable contagiousness of symptoms associated with COVID-19, and considering a personalized medicine approach
- An evolving understanding of the biological characteristics, circumstances, and values that put some patients at elevated risk for developing and spreading the disease
- Stratifying patient groups to identify those who can present severe complications
- Personalized risk assessment that may inform back-to-work strategies, or prompt high-risk patients to take additional safety precautions
PANELISTS:
Jeffrey A. Shaman, PhD, MS, Chief Science Officer, Coriell Life Sciences
Sarah Hersey, MS, MBA, RAC, Vice President, Precision Medicine, Bristol-Myers Squibb Co.
Jay G. Wohlgemuth, MD, Senior Vice President and Chief Medical Officer, Quest Diagnostics and Chair, Personalized Medicine Coalition